The well-known founder of the industry and academia

Director of National International Joint Research Center for Precision Medical Biotherapy of Ministry of Science and Technology

Chief Scientist of the Key Research and Development Program of the Ministry of Science and Technology

Chairman of the Precision Biotherapy Committee of China pharmaceutical quality management association

The winner of Chongqing's "One-Hundred Talents Program", the first batch of "Scientific and Technological Innovation Talents" and "the first batch of One-hundred Leading Talents"

achievements in scientific research:

Presided over the completion of a total of 40 overseas and domestic research projects

Obtained 21 international invention patents and 16 domestic invention patents

More than 170 SCl papers were published, with the total impact factor exceeding 1,000.

Industry experience:

Engaged in basic, transformation and clinical experimental research of tumors for nearly 30 years.

Study the molecular mechanism of tumor microenvironment regulating cancer metastasis and recurrence, and explore new targets for tumor therapy

Developing new strategy of gene therapy for cancer and taking the lead in proposing a new concept of "virus-gene" therapy for cancer

Opening up a new direction of cellular immunotherapy, a number of new cancer cell therapy technologies, approved and successfully treated more than 2,000 cancer patients

Educational background

Education:

Doctor, University of Navarre, Spain

Previous teaching posts:

Director, Biological Treatment Center, Southwest Hospital, Third Military Medical University

Professor, Peking University Hospital of Clinical Oncology

Professor, Center for Applied Medical Research, Spain, and Director of Biotherapy Research Office, University of Navarre

Published more than 460 research papers, and was awarded the "Excellent Achievement Award" by European Association For The Study Of The Liver in 2013.

He has published more than 30 academic papers, and has rich clinical research experience in the field of tumor cell therapy and lung regenerative medicine.

More than 30 years of working experience, with administrative operation, management and sales experience in large state-owned enterprises, private enterprises and listed companies.

Over 30 years of experience in pharmaceutical production quality management

More than 15 years of working experience, focusing on gene, cell technology research and development, cell drug pharmacology and toxicology evaluation experience, etc., presided over 3 national projects, and participated in more than 10 national projects as the backbone.

More than 15 years of experience, focusing on cell therapy, gene, virus combination therapy experience, etc., presided over or participated as the backbone of more than 10 national projects.

More than 10 years of experience, focusing on clinical-grade plasmid, virus, vector and cell product quality management experience, etc.

With over 15 years of experience in the biopharmaceutical industry, Dr. Xu Yanmin brings deep expertise in the development and preclinical research of cell and gene therapies. As a seasoned leader, she has led or played a key role in over 10 national and provincial-level R&D projects, driving innovation and advancement in cutting-edge therapeutic areas.

With over 28 years of experience in sales and marketing leadership roles within global healthcare companies, Xia Junli has served industry leaders such as Merck, Bayer, and Baxter. He brings deep commercialization expertise in the cell and gene therapy space, with over 5 years dedicated to building end-to-end commercial strategies from the ground up. His track record includes successfully establishing high-performance teams, designing innovative access and payment solutions, and developing competitive, market-driven commercial ecosystems.